Kerala CM seeks accountability over SMA trial drug administration to children

Chief Minister Pinarayi Vijayan has demanded swift action from authorities after allegations emerged that children suffering from spinal muscular atrophy (SMA) were administered experimental drugs as part of clinical trials. The development has triggered concerns about the adequacy of informed consent procedures and the protection of vulnerable patient populations in medical research.

The incident has raised questions about the regulatory framework governing clinical trials in Kerala and the broader region. Health officials have been directed to conduct a thorough investigation into the circumstances surrounding the drug administration and to ascertain whether proper protocols were followed during the trial's implementation.

SMA, a rare genetic disorder affecting motor neurons, has no established cure, making affected families vulnerable to experimental treatment options. The case highlights the delicate balance between providing access to potential therapeutic interventions and safeguarding the rights and safety of participants in clinical research.

State health authorities are expected to review existing guidelines for clinical trial approvals and monitor compliance among research institutions. The inquiry will also examine whether ethical clearance procedures were appropriately implemented and whether parents and guardians received complete information regarding the risks and benefits of the experimental treatment.